Latest news on ‘Health & Drug’
-
Diabetes pill controversy shows rift in FDA ranks
WASHINGTON (AP) – The diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week [...]
-
Merck To Close 16 Facilities, Part Of Schering Deal
Merck & Co. (MRK) said Thursday that it would close eight research sites and eight manufacturing plants to hit cost-saving targets promised as a result of last year’s takeover of [...]
-
Health overhaul first provisions start to kick in
WASHINGTON (AP) — The first stage of President Barack Obama’s health care overhaul is expected to provide coverage to about 1 million uninsured Americans by next year, according to government [...]
-
Covidien to Pay $2.6 Billion for Device Maker Ev3
(Bloomberg) — Covidien Plc, the medical-equipment company spun off from Tyco International Ltd., agreed to buy ev3 Inc. for $2.6 billion to add products for heart disease.
Covidien will pay [...] -
Pfizer cuts hundreds of jobs in Britain and Ireland
Andrew Clark in New York – largest drugs company, Pfizer, is to dispose of eight factories and cut 6,000 jobs, including hundreds of positions in Britain and Ireland, as it [...]
-
Investors dump shares of Wellpoint, down 2.2% (WLP)
WellPoint (NYSE:WLP) is one of today’s worst performing stocks, down 2.2% to $50.19. The S&P is currently trading 1% lower to 1,116 and the Dow Jones Industrial Average is trading [...]
-
P&G 3Q profit dips despite sales jump
CINCINNATI (AP) — Consumer products giant Procter & Gamble Co. reported Thursday that its profit fell 1 percent in its third quarter, hurt by charges including from the U.S. health [...]
-
For $520 Million, AstraZeneca Settles Case Over Marketing of a Drug
By DUFF WILSON – AstraZeneca has completed a deal to pay $520 million to settle federal investigations into marketing practices for its blockbuster schizophrenia drug, Seroquel, the Attorney General, Eric [...]
-
Charles River, Chinese Pharma Firm Ink $1.6B Deal
HONG KONG – Charles River Laboratories plans to buy Shanghai-based pharmaceutical outsourcing provider WuXi PharmaTech in a $1.6 billion cash-and-stock deal, the companies announced Monday.
Once complete, the deal could mark [...] -
Judge Invalidates Human Gene Patent
NY Times – A federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer. The decision, if upheld, could throw into doubt the patents [...]
